| Literature DB >> 17172475 |
Michal Nowicki1, Danuta Ostalska-Nowicka, Beata Kondraciuk, Bogdan Miskowiak.
Abstract
The role of substance P (SP) in physiological haematopoiesis is well established. However, it also seems to be important in the neoplastic transformation of bone marrow, leading to the development of acute leukaemia in children, and also metastases to bone marrow of solid tumours (particularly neuroblastoma and breast cancer) in early stages of these diseases. This review summarises the available data on SP involvement in both processes. In the future, SP antagonists may be used as anti-neoplastic drugs, for example by direct or indirect blocking of tumour cell proliferation through inhibition of growth factor production and interleukin-1b synthesis.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17172475 PMCID: PMC1995773 DOI: 10.1136/jcp.2006.041475
Source DB: PubMed Journal: J Clin Pathol ISSN: 0021-9746 Impact factor: 3.411